How to Sell a Medical Practice
How to sell a medical or dental practice in APAC: EBITDA multiples by specialty, who buys healthcare practices, and confidential AI-matched exits.
Medical and dental practices across Asia Pacific are among the most valuable small businesses in the region — and among the least-understood in terms of M&A. Healthcare practices benefit from recurring billing, highly trained workforces, and structural tailwinds from ageing demographics, rising chronic disease burden, and a growing APAC middle class with access to private healthcare.
The buyer universe is deep and well-capitalised: hospital groups, PE-backed healthcare roll-ups, dental consolidators, and Japanese and Korean healthcare strategics are all actively acquiring in APAC. But most practice owners — general practitioners, dental group founders, specialists — have never run a formal M&A process and don’t know what their practice is worth to these buyers.
Amafi is a confidential M&A matching marketplace for medical and dental practice owners. Your practice is matched privately to qualified healthcare buyers without a public listing. See who would buy your practice →
Healthcare buyers remain active, but they are more selective about reimbursement, practitioner dependency, and scalable operating models. PwC’s 2026 health industries M&A outlook frames healthcare M&A around access, innovation, and technology-enabled care, while Bain’s 2026 M&A report includes healthcare and life sciences as a sector where portfolio focus and growth acquisitions remain central. A practice with multi-practitioner depth and clean billing records is easier to finance and diligence than a founder-dependent clinic.
Who Buys Medical Practices in Asia Pacific
Healthcare practice M&A in APAC draws from five main buyer types:
Hospital groups and health system acquirers — Ramsay Health Care, IHH Healthcare (Malaysia/Singapore/Turkey), Bangkok Dusit Medical Services (BDMS), Apollo Hospitals, and Bumrungrad International are expanding their outpatient, specialist, and primary care networks through acquisition. They target practices with established patient bases, specialist practitioners, accreditations, and physical locations in high-growth urban corridors. Platform economics — centralised administration, negotiating power with insurers and government programs, shared procurement — are the core rationale.
PE-backed healthcare roll-ups — Bain Capital Healthcare, Quadria Capital, Mubadala Healthcare, GIC-backed platforms, and regional PE funds (Quadrant Private Equity, Pacific Equity Partners) are building primary care and specialist networks across Australia, Southeast Asia, and India. These buyers value recurring revenue, accredited billing systems, and management teams that can grow under institutional ownership. Multiples from PE buyers are highest for practices with multi-practitioner models, system-independent workflows, and strong billing diversification.
Dental consolidators — The dental sector across APAC is experiencing significant PE consolidation. Dental roll-up platforms — similar to Pacific Smiles, 1300Smiles, and Dental Corporation models in Australia — are being constructed or expanded in Singapore, Malaysia, Vietnam, and Indonesia. These buyers specifically target group dental practices with 3+ chairs, associate models, and management systems that allow scale.
Japanese and Korean healthcare strategics — M3 (Japan’s largest digital healthcare platform), Sony Group Healthcare, Samsung Biologics, and Naver Health are acquiring clinical data, digital health capability, and patient access in APAC. These acquirers are particularly active in genomics, preventive health, and digitally-integrated specialist clinics. They often pay strategic premiums for practices that bring proprietary patient data or clinical workflow systems.
Allied health and integrated care roll-ups — Physiotherapy, psychology, occupational therapy, and rehabilitation service businesses are being consolidated by specialist PE platforms and health system acquirers looking to build integrated ambulatory care networks.
Medical Practice Valuation Multiples in Asia Pacific
Multiples vary by specialty, billing model, and practitioner dependency:
| Practice type | Typical EBITDA multiple | Key value drivers |
|---|---|---|
| Specialist clinic (cardiology, oncology, orthopaedics) | 7–12× | Multiple practitioners, procedural volume, insurer contracts |
| Specialist clinic (dermatology, ophthalmology, urology) | 6–10× | Aesthetic/elective mix, private pay, equipment capability |
| Dental group (3+ chairs, associate model) | 5–9× | Chair utilisation, associate retention, location |
| Primary care / general practice (multi-doctor) | 5–8× | Billing diversification, capitation contracts, patient list |
| Primary care / general practice (single doctor) | 4–6× | Post-succession billing sustainability, location |
| Allied health group (physio, psychology, OT) | 4–7× | NDIS/insurance billing, practitioner continuity |
| Aged care / RACF operator | 4–8× | Regulatory status, occupancy, government funding |
| Diagnostic imaging / pathology | 6–10× | Equipment modernity, referral base, Medicare billing |
Ranges reflect observed APAC mid-market healthcare transactions 2023–2025. Sources: PwC Health Services Deals Outlook 2025; Bain Global Healthcare Private Equity Report 2025.
Single-practitioner practices receive structural discounts unless practitioner succession is resolved pre-sale. Multi-practitioner models with management systems that allow clinical delivery independent of the founder trade at significant premiums.
What Buyers Examine in Medical Practice Due Diligence
Medical practice due diligence covers regulatory, billing, clinical, and financial workstreams:
Regulatory and licensing. Healthcare practice ownership and clinical governance is regulated in every APAC jurisdiction. Buyers examine practitioner registrations (AHPRA in Australia; MOH licensing in Singapore, Malaysia, Thailand; NMC/DMC in India), corporate practice restrictions in the target market, and any regulatory investigations or conditions on practice. Change-of-control notification requirements for Medicare, government funding programs, and private health insurer contracts must be identified and managed.
Billing audit and revenue quality. Medicare billing compliance (in Australia) or government health scheme billing in other jurisdictions is a primary diligence item. Buyers examine billing codes, bulk billing ratios, private health insurance mix, and cash pay composition. Practices with a history of Medicare audits, billing pattern anomalies, or high-risk billing codes receive heightened scrutiny. Revenue concentration by insurer or government program is also analysed — a practice that derives 80% of revenue from one insurer is structurally riskier than one with diversified payers.
Patient record compliance. Patient records (electronic health records, patient data management) must comply with jurisdiction-specific privacy law (Privacy Act 1988 in Australia; PDPA in Singapore; PDPB in India). Buyers examine EHR system quality, data backup and security, and whether patient records are properly maintained, de-identified, and portable on practice change of control. Healthcare data breaches are a significant liability; buyers conduct cybersecurity due diligence.
Practitioner dependency analysis. The single most important commercial diligence item. Buyers model the revenue attributable to each practitioner and assess what portion of that revenue is portable to a new practitioner if the founding doctor exits. Practices where the founder accounts for less than 40% of billings — or where succession practitioners are already in place — attract full-multiple offers. Practices where 70%+ of billings sit with the founding practitioner receive a hold-back or earnout structure.
Equipment condition. Clinical equipment — diagnostic imaging, procedure suites, dental chairs, ultrasound — is assessed for age, maintenance records, software compliance, and replacement cycle timing. Buyers model deferred capex against purchase price; near-term equipment replacement reduces effective multiples.
Accreditation and quality. Hospital accreditation, ISO standards, RACGP accreditation (general practice, Australia), or equivalent quality certification in each jurisdiction is standard. Buyer integration into health system networks often requires specific accreditation; gaps create integration risk and can delay deal close.
Preparing Your Medical Practice for Sale
Preparation 12–24 months before process is particularly important in healthcare:
Address practitioner dependency. Hire associate practitioners who can absorb patient load in a transition period. Structure employment agreements with non-solicitation clauses and retention incentives. Buyers pay significantly more for practices with demonstrated billing transfer to non-founding practitioners. Every percentage point of billing concentration shifted away from the founding doctor before the process starts translates directly into purchase price.
Audit billing and coding. Conduct an internal billing compliance review before buyer due diligence begins. Identify and resolve any billing anomalies; engage a healthcare billing compliance specialist if needed. Clean billing records — without audit flags or coding irregularities — accelerate due diligence and reduce buyer discount.
Maintain accreditation records. Ensure accreditation is current and renewal is scheduled before the process begins. Compile accreditation certificates, quality audit reports, and compliance correspondence. Buyers require sight of full accreditation records before valuation.
Normalise EBITDA. Adjust for owner salary above market rate, personal expenses, one-off equipment purchases, and any non-recurring items. Prepare 3 years of normalised EBITDA with supporting schedules. For multi-practitioner practices, segment billings and EBITDA by practitioner to show the business is not wholly dependent on the founder.
Document patient management systems. Buyers want to know that clinical workflows, appointment systems, patient recall programs, and billing processes are managed systematically — not in the founding doctor’s head. SOPs, EHR configuration documentation, and staff training records all support buyer confidence.
“Medical and dental practices are among the most defensible business models in Asia Pacific — recurring billing, demographic tailwinds, and deeply embedded patient relationships. But practitioner dependency is the single biggest value gap between what a practice earns and what a buyer will pay upfront. The practices that achieve the highest multiples — and the cleanest deal structures — are the ones that spent 18–24 months before the process hiring associates, systematising workflows, and demonstrating that patient revenue survives the founding doctor stepping back.” — Daniel Bae, Founder & CEO, Amafi ($30B+ in M&A transaction experience across Asia Pacific)
Why Confidentiality Is Critical in Medical Practice M&A
Premature disclosure in healthcare creates patient, staff, and regulatory exposure:
Patient trust. Patients who learn a practice is being sold may seek alternative providers — particularly in specialist practices where the relationship with the treating doctor is the core value. Premature announcement can erode the patient list that buyers are paying for.
Clinical staff uncertainty. GPs, nurses, practice managers, and support staff who learn a practice is changing hands often explore alternative positions. Key staff departure before close can affect both operational continuity and post-close transition.
Regulatory notification timing. In Australia, New Zealand, Singapore, and Malaysia, corporate practice ownership and Medicare or government health scheme participation has notification and approval requirements on change of control. Premature disclosure can trigger regulatory review before the deal is structured.
Competitor intelligence. Competitor practices — particularly those in the same catchment area — can use knowledge of a sale process to recruit practitioner staff or aggressively target the departing practice’s patient base.
A confidential sale process using an intermediary, tiered information release under NDA, and no public announcement protects patient relationships and staff stability through the transaction.
Finding the Right Buyers Without Going Public
Amafi is a confidential M&A matching marketplace for medical and dental practice owners who want to explore a sale on their own terms.
How it works:
- Register your practice on Amafi — specialty, geography, revenue, and deal preferences.
- Amafi AI matches your profile privately against qualified healthcare buyers — hospital groups, PE healthcare roll-ups, and dental consolidators — registered with matching acquisition criteria.
- You receive notification that a matched buyer exists. No information about your practice is shared until you approve the introduction.
- Once you approve, both sides receive enough information to assess fit — without a public listing.
- A licensed M&A advisor through Lyndon Advisory manages the formal transaction process once both sides are aligned.
There is no fee to register. Amafi’s success fee is paid through the advisory process on a completed deal.
See who would buy your medical practice →
Related Reading
- How to Sell Your Business Confidentially — the full confidential sale process for any sector
- How to Sell a Dental Practice — dental-specific EBITDA multiples by type, DSO and PE roll-up buyers, practitioner dependency, and APAC market notes
- How to Sell a Veterinary Practice — EBITDA multiples, PE consolidators, and sale process for vet practice owners in APAC
- How to Sell a Pharmacy — pharmacy EBITDA multiples by type, PE roll-up buyers, PBS/reimbursement considerations, and APAC sale process
- How to Sell a Healthcare Business — broader healthcare sector coverage including hospitals and aged care
- Types of Buyers in M&A — PE funds, strategic acquirers, family offices, and search funds compared
- How to Prepare Your Business for Sale — financial, operational, and legal preparation steps before going to market
- How Long Does It Take to Sell a Business? — timeline from preparation to close for mid-market businesses
- EBITDA Multiple — how healthcare practices are valued relative to earnings
- Due Diligence — what buyers examine in a healthcare transaction
Related Guide
For the broader framework behind this topic, see Amafi’s M&A process guide.
